(GLP) |
| 0 (0%) 09-11 12:30 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 63.28 |
| Resistance 1: | 54.18 |
| Pivot price: | 51.73 |
| Support 1: | 50.32 |
| Support 2: | 47.93 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 4.890 |
| Book Value | 19.840 |
| PEG Ratio | 6.18 |
| Gross Profit | 36.928 |
| Profit Margin (%) | 0.81 |
| Operating Margin (%) | 1.59 |
| Return on Assets (ttm) | 5.3 |
| Return on Equity (ttm) | 27.2 |
Company news
Fri, 11 Sep 2026
Mounjaro’s ripple effect: how GLP-1 drugs are changing consumer habits - The Times
Thu, 10 Sep 2026
‘Everything changed’: Woman says grant-funded GLP-1 program helped cure her alcohol addiction - WPRI.com
Thu, 10 Sep 2026
Lilly’s GLP-1 Windfall to Fund Investments in Women’s Health - Bloomberg.com
Thu, 10 Sep 2026
GLP-1 Prescribing in Young Children With Obesity Rises 310-Fold - AJMC
Thu, 10 Sep 2026
‘I’m sick of her talking about it’: 11 readers share how GLP-1s have affected their relationships - The Guardian
Wed, 09 Sep 2026
Can Oral Wegovy Help Novo Nordisk Capture China’s $4.46 Billion GLP-1 Opportunity? - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
